During the past decade, CHU Dijon Bourgogne conducted 723 clinical trials. In the 10-year time frame, 723 clinical trials started and 45 clinical trials were completed, i.e. on average, 6.2% percent of trials that started reached the finish line to date. In the past 5 years, 335 clinical trials started and 32 clinical trials were completed. i.e. 9.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU Dijon Bourgogne" #1 sponsor was "Centre Hospitalier Universitaire Dijon" with 376 trials, followed by "The Lymphoma Academic Research Organisation" with 35 trials sponsored, "Nantes University Hospital" with 34 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 28 trials sponsored and "Assistance Publique - Hôpitaux de Paris" with 28 trials sponsored. Other sponsors include 538 different institutions and companies that sponsored additional 201 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Dijon Bourgogne" #1 collaborator was "Ministry of Health, France" with 30 trials as a collaborator, "Centre Hospitalier Universitaire Dijon" with 10 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 10 trials as a collaborator, "AstraZeneca" with 8 trials as a collaborator and "National Cancer Institute, France" with 8 trials as a collaborator. Other collaborators include 496 different institutions and companies that were collaborators in the rest 367 trials.

According to Clinical.Site data, the most researched conditions in "CHU Dijon Bourgogne" are "Colorectal Cancer" (20 trials), "Multiple Myeloma" (18 trials), "Stroke" (16 trials), "Multiple Sclerosis" (15 trials) and "Diabetes" (9 trials). Many other conditions were trialed in "CHU Dijon Bourgogne" in a lesser frequency.

Most popular intervention types in "CHU Dijon Bourgogne" are "Drug" (382 trials), "Other" (350 trials), "Biological" (121 trials), "Procedure" (112 trials) and "Device" (84 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (54 trials), "Blood samples" (20 trials), "Questionnaires" (18 trials), "Data collection" (16 trials) and "fluorouracil" (14 trials). Other intervention names were less common.

The vast majority of trials in "CHU Dijon Bourgogne" are 975 trials for "All" genders, 43 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are 335 active trials in "CHU Dijon Bourgogne". 23 are not yet recruiting, 243 are recruiting, 67 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 477 completed trials in CHU Dijon Bourgogne, 2 suspended trials, and 62 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Dijon Bourgogne, 26 "Phase 1" clinical trials were conducted, 167 "Phase 2" clinical trials and 204 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 34 trials, and there were also 259 trials that are defined as “Not Applicable".

CHU Dijon Bourgogne has several departments that took part in Clinical trials: "Hématologie Clinique, CHU, Hôpital d'Enfants" - 4 trials, "Hopital du Bocage; Dermatologie" - 4 trials, "Hôpital General - Service de neurologie; Service de neurologie" - 3 trials, "CHU Dijon - Serve de Réanimation" - 2 trials, "Hôpital Champmaillot Geriatric Department" - 2 trials, "Département d'infectiologie, Complexe Bocage, Hôpital d'enfants, CHU de Dijon" - 2 trials, "Cardiovascular and thoracic surgery unit, CHU Dijon" - 2 trials